Yüklüyor......
The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression
Multiple mechanisms contribute to the survival and growth of metastatic castration‐resistant prostate cancer (mCRPC) cells without androgen, including androgen receptor splice variants (AR‐V) and de novo intratumoral androgen synthesis. AKR1C3 is a critical androgenic enzyme that plays different rol...
Kaydedildi:
| Yayımlandı: | J Cell Mol Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7579719/ https://ncbi.nlm.nih.gov/pubmed/32902124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15831 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|